Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.

Thompson RH, Boorjian SA, Kim SP, Cheville JC, Thapa P, Tarrel R, Dronca R, Costello B, Frank I.

BJU Int. 2014 May;113(5b):E17-21. doi: 10.1111/bju.12274. Epub 2013 Sep 5.

PMID:
24006893
[PubMed - indexed for MEDLINE]
2.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G.

Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.

PMID:
20472172
[PubMed - indexed for MEDLINE]
3.

Blinded comparison of cranial CT and MR in closed head injury evaluation.

Orrison WW, Gentry LR, Stimac GK, Tarrel RM, Espinosa MC, Cobb LC.

AJNR Am J Neuroradiol. 1994 Feb;15(2):351-6.

PMID:
8192085
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk